🇺🇸 FDA
Patent

US 11154556

Methods of treating solid tumors with CCR2 antagonists

granted A61KA61K31/4433A61K31/453

Quick answer

US patent 11154556 (Methods of treating solid tumors with CCR2 antagonists) held by The Regents of the University of California expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4433, A61K31/453, A61K31/536, A61K45/06